Loading insider details...
Beta
Latest Form 4 (Oct 2, 2026): Grant/Award of 300,000 TCRX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 2, 2026 | TScan Therapeutics, Inc. (TCRX) | Grant/Award | 300,000 | n/a |
| Jan 22, 2026 | TScan Therapeutics, Inc. (TCRX) | Grant/Award | 350,000 | n/a |
| Feb 11, 2025 | TScan Therapeutics, Inc. (TCRX) | Grant/Award | 52,500 | n/a |
| Aug 27, 2024 | TScan Therapeutics, Inc. (TCRX) | Exercise/Conversion | 54,895 | $266.2K |
| Jun 15, 2023 | TScan Therapeutics, Inc. (TCRX) | Grant/Award | 430,000 | n/a |
| Feb 6, 2023 | TScan Therapeutics, Inc. (TCRX) | Grant/Award | 35,000 | n/a |
| Jul 27, 2022 | TScan Therapeutics, Inc. (TCRX) | Grant/Award | 50,000 | n/a |
| Jan 20, 2022 | TScan Therapeutics, Inc. (TCRX) | Grant/Award | 85,000 | n/a |
| Sep 27, 2021 | TScan Therapeutics, Inc. (TCRX) | Purchase | 4,716 | $35.3K |
| Sep 9, 2021 | TScan Therapeutics, Inc. (TCRX) | Grant/Award | 150,000 | n/a |